Roche

Europe’s Drugmakers May Boost Acquisitions After Buyback Focus
Bloomberg Businessweek
Thu, 01/12/12 - 02:11 pm
Europe
M&A
patents
GSK
Roche
AstraZeneca
Novartis
Interferon's Role In Flu Control Shouldn't Be Underestimated
Seeking Alpha
Thu, 01/12/12 - 09:11 am
interferon
Flu
Hemispherx
Roche
Novavax
Sinovac
$3B or less is Big Pharma's M&A sweet spot
Fierce Pharma
Wed, 01/11/12 - 12:58 pm
M&A
Roche
Sanofi
Bristol-Myers Squibb
Novartis
Pfizer
Merck
3 Reasons Hep C Premiums Might Not Last
Motley Fool
Tue, 01/10/12 - 09:50 am
hepatitis C
Anadys
Roche
Gilead
Pharmasset
Bristol-Myers Squibb
Inhibitex
Galena Biopharma announces FDA approves IND application
Yahoo/Fly on the Wall
Thu, 01/5/12 - 12:38 pm
Galena Biopharma
FDA
NeuVax
Herceptin
Roche
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
Year in Review: Melanoma Drug Still on a Roll
Med Page Today
Wed, 12/28/11 - 03:16 pm
melanoma
Zelboraf
Roche
EU OKs Roche's Avastin for ovarian cancer
Reuters
Fri, 12/23/11 - 08:50 am
Europe
Avastin
ovarian cancer
Roche
Roche Is Open to $3 Billion Deal, Would ‘Seize’ Opportunity
Bloomberg Businessweek
Thu, 12/22/11 - 08:57 am
Roche
M&A
Severin Schwan
10 Biotech Stock Predictions for 2012
TheStreet.com
Tue, 12/20/11 - 11:13 am
Amgen
FDA
Oncothyreon
Merck KGaA
Vical
GSK
Seattle Genetics
M&A
Celgene
Biomarin
Amag Pharmaceuticals
Momenta
ONYX Pharmaceuticals
Cell Therapeutics
Roche
Aeterna Zentaris
Arena Pharmaceuticals
Vertex
Spectrum Pharmaceuticals
Roche melanoma drug wins European green light
Reuters
Fri, 12/16/11 - 10:30 am
Roche
melanoma
Europe
EMA
Zelboraf
2012 Preview: Cancer Immunotherapy Catalysts
Seeking Alpha
Thu, 12/15/11 - 12:08 pm
cancer
Antigenics
Amgen
Bristol-Myers Squibb
Celgene
Dendreon
Generex
Merck KGaA
GSK
Idera Pharmaceuticals
NewLink Genetics
Novartis
Roche
Oncothyreon
Transgene
Vical
Fat-Burning Roche Medicine Stops Diabetes in Mice Study, Researchers Say
Bloomberg
Wed, 12/14/11 - 06:44 pm
Roche
diabetes
FGF21
9 Biotech Companies With FDA Approval Decision Dates In Q1 2012
Seeking Alpha
Mon, 12/12/11 - 11:14 am
FDA
Fentanyl SL
INSYS Therapeutics
Dapagliflozin
Bristol-Myers Squibb
Prochieve
Columbia Laboratories
Discovery Labs
Surfaxin
NeurogesX
Qutenza
Curis
Roche
vismodegib
Chelsea Therapeutics
Northera
ONYX Pharmaceuticals
Carfilzomib
Roche, Labcyte to team on PCR
Thu, 12/8/11 - 10:20 pm
Roche
PCR
Hungry biotechs make better partners for Big Pharma
Fierce Biotech
Thu, 12/8/11 - 11:58 am
biotech
Big Pharma
Roche
Zelboraf
vismodegib
New Setback for Avastin as Breast Cancer Treatment
NY Times, NY
Thu, 12/8/11 - 11:39 am
breast cancer
Avastin
Roche
Genentech
Roche and Pfizer launch pharma's first official Google+ pages
PM Live
Tue, 12/6/11 - 11:40 am
Roche
Pfizer
social media
Google+
Regeneron Drops as Eye Drug Shown Similar to Roche's Lucentis
Bloomberg Businessweek
Mon, 12/5/11 - 12:28 pm
Roche
Lucentis
Regeneron
Eyela
wet-AMD
Roche Pays $20M To Settle Whistleblower Lawsuit
Pharmalot
Fri, 12/2/11 - 11:20 am
Roche
whistleblower lawsuits
Rituxan
Medicare
Medicaid

Pages